The France-based Guerbet Group is highly specialized in contrast media for medical imaging. Its strategic goal is to be a key player in this market. Guerbet Group produces products for x-ray imaging, MRI, ultrasound imaging and imaging through radioactive tracers.

Oxilan® is a radiographic contrast agent used in diagnostic imaging studies. The degree of contrast enhancement is directly related to the iodine content in the administered dose. Dependent on the iodine content, the osmolalities are 2.1 or 2.4 times that of plasma (285 mOsm/kg water).